Search results
AstraZeneca’s Fasenra: Approval for asthma may initiate COPD approval
Pharmaceutical Technology via Yahoo Finance· 6 days agoAccording to leading data and analytics company GlobalData’s...reduce exacerbations and manage the...
Small Business - Cordele Dispatch | Cordele Dispatch
Cordele Dispatch· 3 days agoPDUFA Target Action Date of June 26, 2024 Eight posters including two oral presentations support potential of ensifentrine,an investigational, first-in-class, selective, dual inhibitor of PDE3 and PDE4 LONDON and RALEIGH, N.C., May 02, 2024
AMGEN HIGHLIGHTS NEW COPD, ASTHMA AND VASCULITIS RESEARCH AT ATS 2024
Morningstar· 4 days agoSociety (ATS) 2024 International Conference taking place May 12-22 in San Diego. "We look forward to presenting encouraging data from our Phase 2a COURSE trial in COPD with ...
Earnings call: Regeneron reports steady growth, prepares for new launches By Investing.com
Investing.com· 3 days agoThis growth was primarily driven by strong sales of Dupixent and Libtayo, as well as collaboration...
Mesothelioma
Health· 2 days agoRelated conditions include: Chronic obstructive pulmonary disease (COPD): Affects your breathing ability and blocks airflow Coronary artery disease...
Regeneron Reverses On Better-Than-Feared Eylea Sales As Patent Expiration Looms
Investor's Business Daily· 3 days agoRegeneron stock is forming a flat base with a buy point at 998.33, according to MarketSurge. That's...
Regeneron Pharmaceuticals Inc (REGN) Q1 2024 Earnings Call Transcript Highlights: Key Financial ...
GuruFocus.com via Yahoo Finance· 2 days agoRegeneron Pharmaceuticals Inc (NASDAQ:REGN) and Sanofi's sBLA for Dupixent for COPD treatment was accepted by the FDA for priority review, highlighting ...
Earnings call: Amgen reports robust Q1 2024 sales and pipeline progress By Investing.com
Investing.com· 2 days agoThe biotechnology company has seen a 22% increase in sales, driven by key products such as Repatha,...
11 Oversold Growth Stocks to Buy Right Now
Insider Monkey via Yahoo Finance· 7 days agoIn this article, we will take a look at the 11 oversold growth stocks to buy right now. To skip our analysis of the recent trends and market activity,...
AstraZeneca to present respiratory disease research at ATS 2024 By Investing.com
Investing.com· 4 days agoDiego, California. The pharmaceutical company announced today that it will showcase 59 abstracts,...
